WADA 2026 Prohibited List Status (Section S0) Retatrutide is not currently named explicitly on the World Anti-Doping Agency 2025 or 2026 Prohibited Lists but falls within section S0 (Non-Approved Substances), which covers any pharmacological substance not currently approved by a governmental health authority for human therapeutic use
Initially, injections may be given weekly or biweekly until levels improve, followed by maintenance doses every 1-3 months
Quick answer In the research literature, the 12 mg AOD-9604 + CJC-1295 + Ipamorelin blend vial is typically reconstituted with 3 mL of bacteriostatic water, and documented research protocols reference roughly 400 mcg per dose drawn from that solution
Research literature frequently references both peptides individually in experimental studies involving peptide chemistry, molecular biology, biochemical analysis, and preclinical laboratory investigations
This protects cells from oxidative damage while reducing the inflammatory burden
